Hoerter Steven L.
SEC CIK 1533451 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | Pres, CEO, Dir | 82.9K | $265.0K | — | 3 | 2025-10-17 | 2026-08-03 |
Most active insiders at MBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FHMLS X, L.P. | 10% | $12.00M | — |
| 2 | Azoulay Salomon | Chief Medical Off | — | $2.72M |
| 3 | Hawryluk P. Kent | Pres, CEO, Dir | $798.4K | $17.9K |
| 4 | Hoerter Steven L. | Pres, CEO, Dir | $265.0K | — |
| 5 | Bartram Richard | CFO | — | — |
| 6 | Smither John W | CFO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-04 08:50 | 2026-08-03 | MBX | MBX Biosciences, Inc. | Hoerter Steven L. | Pres, CEO, Dir | A - Grant | $0.00 | +71.0K | 82.9K | +595% | $0 |
| D | 2026-05-04 08:01 | 2026-05-01 | MBX | MBX Biosciences, Inc. | Hoerter Steven L. | Dir | A - Grant | $0.00 | +11.9K | 11.9K | New | $0 |
| I | 2025-10-20 | 2025-10-17 | MBX | MBX Biosciences, Inc. | Hoerter Steven L. | Dir | P - Purchase | $13.25 | +20.0K | 20.0K | New | +$265.0K |
Purchase Sale Sale after option exercise All abbreviations